Periodontal Therapeutics Market

Periodontal disease, commonly known as gum disease, is where the periodontal tissues surrounding the teeth are in a pathological inflammatory condition. Periodontitis is relatively common, usually caused by poor oral hygiene, and can be prevented in most cases. Periodontitis can lead to tooth loss and is a risk factor for heart and lung diseases. Its symptoms include red swollen and tender gums. Periodontal therapeutics is the non-surgical treatment for periodontal diseases.

The Global Periodontal Therapeutics market was valued at USD XX million in 2018 and expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.

Global Periodontal Therapeutics Market Dynamics

The global market for the periodontal therapeutics market is primarily driven by the increasing prevalence of periodontal diseases, rise in several diabetic patients, and geriatric population. According to the American Academy of Periodontology, diabetes population is more vulnerable to periodontal diseases. According to the WHO, in 2016, the Global Burden of Disease Study estimated that oral diseases affected 3.58 billion people, which is half of the world’s population and severe periodontal disease was estimated to be the 11th most prevalent disease globally. According to the International Diabetes Federation (IDF), in 2017, approximately 425 million adults (20-79 years) were living with diabetes worldwide, and it is projected to be 629 million by 2045. According to the WHO, in 2017, there was approximately 962 million people of age 60 years or over in the world, comprising 13% of the global population and is expected to be 1.4 billion in 2030. According to the NIH, 17.20% of the geriatric population (65+ years) suffer from periodontal disease, and 10.58% of the same age group have moderate or severe periodontal disease.

However, the lack of reimbursement policies and the risk of inducing antibiotic resistance may hinder market progress.      

Global Periodontal Therapeutics Market – Segment Analysis

By Therapeutic Type, the Global Periodontal Therapeutics Market is bifurcated into Systemic Antibiotics and Local Antibiotics. Systemic Antibiotics hold the most significant market share owing to the product affordability, easier availability, and high market penetration. Systemic Antibiotics is further sub-segmented into Doxycycline, Minocycline, Metronidazole, and others. However, the overuse of Systemic antibiotics can lead to the development of antibiotic-resistant strains, which causes patients to respond inadequately to the antibiotics, which is increasing the preference of local antibiotics among patients. Local Antibiotics market share is anticipated to show a significant market growth owing to the growing preference for controlled local drug delivery as it has a low dose requirement, is site specific and has reduced side effects. Furthermore, Local Antibiotics have shown to be an effective and safe mode of treatment. Local Antibiotics is further sub-segmented into Arestin, Atridox, PerioChip, and others.

Global Periodontal Therapeutics Market– Geographical Analysis

North America accounts for the most significant market share in the global market and is mainly attributed to the growing patient pool with periodontal diseases, increasing geriatric population and diabetic population in the region. According to the CDC, 50% of Americans aged 30 or older have periodontitis, the more advanced form of periodontal disease. It equals to approximately 64.7 million Americans. Moreover, other factors increasing the regional market share are the rise in healthcare expenditure, advanced healthcare infrastructure, high level of drug development, presence of established market players, high investment in R&D activities by key players and presence of proper regulatory framework for periodontal drugs.

The Asia Pacific region is expected to witness a significant growth owing it to the increasing rise in the prevalence of periodontal diseases, geriatric population, and diabetic population. There are over 10 million cases of periodontal diseases per year in India. According to the United Nations ESCAP in 2016, approximately 12.4% of the population in the Asia Pacific was 60+ years, but this is projected to increase to more than 1.3 billion people by 2050. According to the International Diabetes Federation (IDF) in 2017, an estimated 82 million adults were living with diabetes in the South-East Asian region, and an estimated 158.8 million adults were living with diabetes in Western Pacific region. Moreover, the increased spending on healthcare, improving healthcare infrastructure in the region, and growing investments by key market players of the area are expected to drive the regional market.

Global Periodontal Therapeutics Market– Competitive Analysis

Several key companies have adopted merger and acquisitions policies, geographic expansion, innovative product launches, and collaborations to help them to gain prominence as strong competitors in the market and also expand its sales in the global Periodontal Therapeutics market. Major Players in the global Periodontal Therapeutics market include 3M, Den-Mat Holdings, Dexcel Pharma, Valeant Pharmaceuticals International Inc., Kaken Pharmaceutical Co. Ltd., and Galderma S.A.

Market Taxonomy:

On the bases of Therapeutic Type, the global Periodontal Therapeutics market is segmented into:

  • Systemic Antibiotics     
    • Doxycycline
    • Minocycline
    • Metronidazole
    • Others
  • Local Antibiotics
    • Arestin
    • Atridox
    • PerioChip
    • Others

On the bases of Distribution Channel, the global Periodontal Therapeutics market is segmented into:

  • Hospital Pharmacies    
  • Retail Pharmacies         
  • E-commerce      

On the bases of region, the global Periodontal Therapeutics market is segmented into:

  • North America     
  • South America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Takeaways:

  • The global market for the Periodontal Therapeutics Market is primarily driven by the increasing prevalence of periodontal diseases, rise in several diabetic patients, and geriatric population.  
  • Systemic Antibiotics hold the most significant market share owing to the product affordability, easier availability, and high market penetration. However, Local Antibiotics market share is anticipated to show a significant market growth owing to the growing preference for controlled local drug delivery as it has a low dose requirement, is site specific and has reduced side effects.
  • North America accounts for the most significant market share in the global market and is mainly attributed to the growing patient pool with periodontal diseases, increasing geriatric population and diabetic population in the region.

Why Purchase the Report?

  • Visualize the composition of the global Periodontal Therapeutics Market across each indication, in terms of Type and Delivery Mode options, highlighting the key commercial assets and players.
  • Identify commercial opportunities in global Periodontal Therapeutics Market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the global Periodontal Therapeutics Market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Type mapping in excel for the key Services of all major market players

Target Audience:

  • Equipment Suppliers/ Buyers
  • Type Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
  1. Global Periodontal Therapeutics Market -Scope and Methodology
    1. Research Methodology
    2. Scope of the market
  2. Global Periodontal Therapeutics Market -Key Trends and Developments
    1. Key Trends and Developments
  3. Global Periodontal Therapeutics Market – Executive Summary
    1. Market Snippet By Therapeutic Type
    2. Market Snippet By Distribution Channel
    3. Market Snippet By Region
    4. DataM CLO Scenario
  4. Global Periodontal Therapeutics Market Dynamics
    1. Market impacting factors
      1. Drivers
        1. Increasing prevalence of periodontal diseases
        2. Rise in number of diabetic patients and geriatric population
        3. Driver 3
      2. Restraints
        1. Lack of reimbursement policies
        2. Restraint 2
      3. Opportunity
    2. Impact analysis
  5. Global Periodontal Therapeutics Market – Industry Analysis
    1. Porter's five forces analysis
    2. Supply chain analysis
    3. Pricing analysis
    4. Regulatory analysis
    5. Patent analysis
  6. Global Periodontal Therapeutics Market – By Therapeutic Type
    1. Introduction
    2. Market size analysis, and y-o-y growth analysis (%), By Therapeutic Type segment
    3. Market attractiveness index, By Therapeutic Type segment
    4. Systemic Antibiotics         
      1. Introduction
      2. Market size analysis, and y-o-y growth analysis (%)
      3. Doxycycline
      4. Minocycline
      5. Metronidazole
      6. Others
    5. Local Antibiotics
      1. Arestin
      2. Atridox
      3. PerioChip
      4. Others
  7. Global Periodontal Therapeutics Market – By Distribution Channel
    1. Introduction
    2. Market size analysis, and y-o-y growth analysis (%), By  Distribution Channel segment
    3. Market attractiveness index, By  Distribution Channel segment
    4. Hospital Pharmacies         
      1. Introduction
      2. Market size analysis, y-o-y growth analysis (%)
    5. Retail Pharmacies 
    6. E-commerce           
  8. Global Periodontal Therapeutics Market – By Region
    1. Introduction
    2. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key region-specific dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By  Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By  Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. The Middle East And Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
  9. Global Periodontal Therapeutics Market – Competitive Landscape
    1. Competitive scenario
    2. Competitor strategy analysis
    3. Comparative type portfolio analysis
    4. Market positioning/share analysis
    5. Mergers and acquisitions analysis
  10. Company Profiles
    1. 3M
      1. Company Overview
      2. Type Portfolio And Description
      3. Key Highlights
      4. Financial Overview
    2. Den-Mat Holdings, LLC
    3. Dexcel Pharma
    4. Valeant Pharmaceuticals International Inc.
    5. Kaken Pharmaceutical Co. Ltd.
    6. Galderma S.A.
    7. OraPharma Inc
    8. Dentsply International
  11. Global Periodontal Therapeutics Market – Premium Insights
  12. Global Periodontal Therapeutics Market – DataM
    1. Appendix
    2. About us and services
    3. Contact us

LIST OF TABLES

Table 1 Global Periodontal Therapeutics Market Value, By Therapeutic Type, 2018,2022 & 2026 ($ Million)

Table 2 Global Periodontal Therapeutics Market Value, By Distribution Channel, 2018,2022 & 2026 ($ Million)

Table 3 Global Periodontal Therapeutics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 4 Global Periodontal Therapeutics Market Value, By Therapeutic Type, 2018,2022 & 2026 ($ Million)

Table 5 Global Periodontal Therapeutics Market Value, By Therapeutic Type, 2017-2026 ($ Million)

Table 6 Global Periodontal Therapeutics Market Value, By Distribution Channel, 2018,2022 & 2026 ($ Million)

Table 7 Global Periodontal Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 8 Global Periodontal Therapeutics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 9 Global Periodontal Therapeutics Market Value, By Region, 2017-2026 ($ Million)

Table 10 North America Periodontal Therapeutics Market Value, By Therapeutic Type, 2017-2026 ($ Million)

Table 11 North America Periodontal Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 12 North America Periodontal Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 13 South America Periodontal Therapeutics Market Value, By Therapeutic Type, 2017-2026 ($ Million)

Table 14 South America Periodontal Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 15 South America Periodontal Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 16 Europe Periodontal Therapeutics Market Value, By Therapeutic Type, 2017-2026 ($ Million)

Table 17 Europe Periodontal Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 18 Europe Periodontal Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 19 Asia-Pacific Periodontal Therapeutics Market Value, By Therapeutic Type, 2017-2026 ($ Million)

Table 20 Asia-Pacific Periodontal Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 21 Asia-Pacific Periodontal Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 22 Middle East & Africa Periodontal Therapeutics Market Value, By Therapeutic Type, 2017-2026 ($ Million)

Table 23 Middle East & Africa Periodontal Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 24 3M: Overview

Table 25 3M: Product Portfolio

Table 26 3M: Key Developments

Table 27 Den-Mat Holdings, LLC: Overview

Table 28 Den-Mat Holdings, LLC: Product Portfolio

Table 29 Den-Mat Holdings, LLC: Key Developments

Table 30 Dexcel Pharma: Overview

Table 31 Dexcel Pharma: Product Portfolio

Table 32 Dexcel Pharma: Key Developments

Table 33 Valeant Pharmaceuticals International Inc.: Overview

Table 34 Valeant Pharmaceuticals International Inc.: Product Portfolio

Table 35 Valeant Pharmaceuticals International Inc.: Key Developments

Table 36 Kaken Pharmaceutical Co. Ltd.: Overview

Table 37 Kaken Pharmaceutical Co. Ltd.: Product Portfolio

Table 38 Kaken Pharmaceutical Co. Ltd.: Key Developments

Table 39 Galderma S.A.: Overview

Table 40 Galderma S.A.: Product Portfolio

Table 41 Galderma S.A.: Key Developments

Table 42 OraPharma Inc: Overview

Table 43 OraPharma Inc: Product Portfolio

Table 44 OraPharma Inc: Key Developments

Table 45 Dentsply International: Overview

Table 46 Dentsply International: Product Portfolio

Table 47 Dentsply International: Key Developments

LIST OF FIGURES

Figure 1 Global Periodontal Therapeutics Market Share, By Therapeutic Type, 2018 & 2026 (%)

Figure 2 Global Periodontal Therapeutics Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 3 Global Periodontal Therapeutics Market Share, By Region, 2018 & 2026 (%)

Figure 4 Global Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 5 Global Periodontal Therapeutics Market Y-o-Y Growth, By Therapeutic Type, 2018-2026 (%)

Figure 6 Systemic Antibiotics: Global Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 7 Local Antibiotics: Global Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 8 Global Periodontal Therapeutics Market Y-o-Y Growth, By Distribution Channel, 2018-2026 (%)

Figure 9 Hospital Pharmacies: Global Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 10 Retail Pharmacies: Global Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 11 E-commerce: Global Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 12 North America Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 13 North America Periodontal Therapeutics Market Share, By Therapeutic Type, 2018 & 2026 (%)

Figure 14 North America Periodontal Therapeutics Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 15 North America Periodontal Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 16 South America Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 17 South America Periodontal Therapeutics Market Share, By Therapeutic Type, 2018 & 2026 (%)

Figure 18 South America Periodontal Therapeutics Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 19 South America Periodontal Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 20 Europe Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 21 Europe Periodontal Therapeutics Market Share, By Therapeutic Type, 2018 & 2026 (%)

Figure 22 Europe Periodontal Therapeutics Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 23 Europe Periodontal Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 24 Asia-Pacific Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 25 Asia-Pacific Periodontal Therapeutics Market Share, By Therapeutic Type, 2018 & 2026 (%)

Figure 26 Asia-Pacific Periodontal Therapeutics Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 27 Asia-Pacific Periodontal Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 28 Middle East & Africa Periodontal Therapeutics Market Value, 2017-2026 ($ Million)

Figure 29 Middle East & Africa Periodontal Therapeutics Market Share, By Therapeutic Type, 2018 & 2026 (%)

Figure 30 Middle East & Africa Periodontal Therapeutics Market Share, By Distribution Channel, 2018 & 2026 (%)

Figure 31 3M: Financials

Figure 32 Den-Mat Holdings, LLC: Financials

Figure 33 Dexcel Pharma: Financials

Figure 34 Valeant Pharmaceuticals International Inc.: Financials

Figure 35 Kaken Pharmaceutical Co. Ltd.: Financials

Figure 36 Galderma S.A.: Financials

Figure 37 OraPharma Inc: Financials

Figure 38 Dentsply International: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report